Andere talen Scancell Holdings plc

Aandelen

Vertraagde tijd London S.E. Andere beurzen 12:41:36 02-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10,59 ^GBX	-4,81%		-4,81%	+0,86%

12:55	Scancell verlengt aflossingsdata converteerbare leningen	MT
12/06	Scancell-aandelen stijgen na exclusieve overeenkomst voor medicijnbeoordeling	AN

Scancell Extends Redemption Dates of Convertible Loan Notes	12:55
Shares in Scancell climb as strikes exclusive drug evaluation deal	12/06
Scancell Gets UK Approval to Add Expansion Cohort to Cancer Vaccine Trial	30/05
Scancell Holdings Receives MHRA Approval To Expand Modify Trial	30/05
Scancell Holdings plc Provides Update on ModiFY Trial	30/05
Scancell : Interim Report 31st October 2023	21/05
Scancell doses first patient in melanoma-focused trials	26/03
Seneca Growth Capital announces tepid 2023 results	22/03
Scancell Holdings plc Appoints Sath Nirmalananthan to the Board	14/03
Alliance Pharma appoints chair; FireAngel sales down	05/02
Scancell's Chief Development Officer to Step Down	05/02
Scancell Holdings plc Directorate and Executive Changes Changes	05/02
Scancell interim loss narrows amid finance gain on derivative	30/01
Scancell Holdings plc Reports Earnings Results for the Half Year Ended October 31, 2023	30/01
Scancell approved by MHRA to add new cohort to Scope trial	17/01
Scancell Holdings plc Announces Update on SCOPE Trial	17/01
Scancell Raises GBP1.2 Million Via Open Offer	19/12
Scancell raises GBP12 million in total from fundraise	19/12
Scancell Raises GBP11 Million via Share Issue	01/12
Scancell raises GBP10.7 million in upsized share sale	01/12

Geen resultaten voor deze zoekopdracht